Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 75,000.0 | $8.8M | 0.30% | -325K | -81.3% | $117.07 | -15.9% |
| 62 | CRY | ARTIVION INC | — | 388,000.0 | $8.7M | 0.30% | NEW | — | $22.47 | -22.0% |
| 63 | TNDM | TANDEM DIABETES CARE INC | Healthcare | 575,000.0 | $8.7M | 0.30% | -208K | -26.6% | $15.09 | +41.6% |
| 64 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 165,677.0 | $8.4M | 0.29% | -65K | -28.2% | $50.75 | +19.9% |
| 65 | SION | SIONNA THERAPEUTICS INC | Healthcare | 177,687.0 | $7.8M | 0.27% | -116K | -39.5% | $43.99 | -86.0% |
| 66 | BLTE | BELITE BIO INC | Healthcare | 50,524.0 | $7.8M | 0.27% | NEW | — | $153.99 | +1.8% |
| 67 | CERS | CERUS CORP | Healthcare | 2,500,000.0 | $7.3M | 0.25% | -8.3M | -76.8% | $2.92 | -6.2% |
| 68 | SLN | SILENCE THERAPEUTICS PLC | Healthcare | 630,000.0 | $6.9M | 0.24% | NEW | — | $10.98 | +23.2% |
| 69 | IMUX | IMMUNIC INC | Healthcare | 450,000.0 | $6.9M | 0.24% | NEW | — | $15.37 | +7.3% |
| 70 | IVVD | INVIVYD INC | Healthcare | 7,708,727.0 | $6.7M | 0.23% | — | — | $0.87 | +3.4% |
| 71 | MRK | MERCK & CO INC | Healthcare | 50,000.0 | $6.4M | 0.22% | -153K | -75.4% | $128.50 | +19.2% |
| 72 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 842,106.0 | $5.8M | 0.20% | — | — | $6.92 | -34.2% |
| 73 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 107,000.0 | $5.7M | 0.20% | +27K | +33.8% | $53.67 | -8.0% |
| 74 | EOLS | EVOLUS INC | Healthcare | 822,428.0 | $5.7M | 0.20% | -1.4M | -63.4% | $6.94 | +26.5% |
| 75 | ANL | ADLAI NORTYE LTD | Healthcare | 405,523.0 | $4.7M | 0.16% | NEW | — | $11.50 | +31.0% |
| 76 | ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | 950,000.0 | $4.6M | 0.16% | NEW | — | $4.85 | -19.8% |
| 77 | KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | 440,000.0 | $4.3M | 0.15% | — | — | $9.77 | -79.9% |
| 78 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 7,063,141.0 | $3.9M | 0.14% | +100K | +1.4% | $0.55 | -23.5% |
| 79 | LUNG | PULMONX CORP | Healthcare | 2,788,323.0 | $3.6M | 0.12% | — | — | $1.30 | +92.3% |
| 80 | — | SAB BIOTHERAPEUTICS INC | — | 900,000.0 | $3.5M | 0.12% | -150K | -14.3% | $3.90 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%